Staff information

PNNL Publications

2024

• Liu J., S. Cao, K.J. Imbach, M.A. Gritsenko, T.M. Lih, J.E. Kyle, and T.M. Yaron, et al. 2024. "Multi-scale signaling and tumor evolution in high-grade gliomas." Cancer Cell 42, no. 7:P1217-1238.E19. PNNL-SA-189873. doi:10.1016/j.ccell.2024.06.004
• Moradian A., E. Goonatileke, T. Lin, M. Hatten-Beck, M. Emrick, A.A. Schepmoes, and T.L. Fillmore, et al. 2024. "Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin." Clinical Chemistry 70, no. 6:855-864. PNNL-SA-189979. doi:10.1093/clinchem/hvae034
• Webb-Robertson B.M., E.S. Nakayasu, F. Dong, K.C. Waugh, J.E. Flores, L.M. Bramer, and A.A. Schepmoes, et al. 2024. "Decrease in multiple complement protein levels associated with development of islet autoimmunity and type 1 diabetes." iScience 27, no. 2:Art. No. 108769. PNNL-SA-177389. doi:10.1016/j.isci.2023.108769
• Zhang Y., V. Bharathi, T. Dokoshi, J. de Anda, L. Tumey Ursery, N.N. Kulkarni, and Y. Nakamura, et al. 2024. "Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes." Proceedings of the National Academy of Sciences (PNAS) 121, no. 6:Art. No. e2300644120. PNNL-SA-192774. doi:10.1073/pnas.2300644120

2023

• Bramer L.M., R. Hontz, A.J. Eisfeld, A.C. Sims, Y. Kim, K.G. Stratton, and C.D. Nicora, et al. 2023. "Multi-omics of NET Formation and Correlations with CNDP1, PSPB, and L-Cystine Levels in Severe and Mild COVID-19 Infections." Heliyon 9, no. 3:13795. PNNL-SA-169411. doi:10.1016/j.heliyon.2023.e13795
• Dou Y., L. Katsnelson, M.A. Gritsenko, Y. Hu, B. Reva, R. Hong, and Y. Wang, et al. 2023. "Proteogenomic insights suggest druggable pathways in endometrial carcinoma." Cancer Cell 41, no. 9:1586-1605.e15. PNNL-SA-177735. doi:10.1016/j.ccell.2023.07.007
• Fritch E.J., W. Sanders, A.C. Sims, L. Herring, N.K. Barker, A.A. Schepmoes, and K.K. Weitz, et al. 2023. "Metatranscriptomics analysis reveals a novel transcriptional and translational landscape during Middle East Respiratory Syndrome Coronavirus infection." iScience 26, no. 6:Art. No. 106780. PNNL-SA-174528. doi:10.1016/j.isci.2023.106780
• Leiser O.P., D.L. Auberry, E. Bakker, W.B. Chrisler, K.M. Engbrecht, H.E. Engelmann, and S.J. Fansler, et al. 2023. "Insights from a workplace SARS-CoV-2 specimen collection program, with genomes placed into global sequence phylogeny." PLoS One 18, no. 4:Art. No. e0285042. PNNL-SA-179220. doi:10.1371/journal.pone.0285042
• Nakayasu E.S., L.M. Bramer, C.K. Ansong, A.A. Schepmoes, T.L. Fillmore, M.A. Gritsenko, and T.R. Clauss, et al. 2023. "Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity." Cell Reports Medicine 4, no. 7:Art. No. 101093. PNNL-SA-137771. doi:10.1016/j.xcrm.2023.101093

2022

• Bruna Brasil B., S. Massaji, T. Batista, J. Hu, S. Nie, A.A. Schepmoes, and L. BonDurant, et al. 2022. "Apolipoprotein C3 and Circulating Mediators of Preadipocyte Proliferation in States of Lipodystrophy." Molecular Metabolism 64. PNNL-SA-171123. doi:10.1016/j.molmet.2022.101572
• Xu G., T.D. Grimes, T.B. Grayson, J. Chen, L.A. Thielen, H.M. Tse, and P. Li, et al. 2022. "Exploratory Study Reveals Far Reaching Systemic and Cellular Effects of Verapamil Treatment in Subjects with Type 1 Diabetes." Nature Communications 13. PNNL-SA-160227. doi:10.1038/s41467-022-28826-3

2021

• Joshi S.K., T. Nechiporuk, D. Bottomly, P.D. Piehowski, J. Reisz, J. Pittsenbarger, and A. Kaempf, et al. 2021. "The AML microenvironment catalyzes a step-wise evolution to gilteritinib resistance." Cancer Cell 39, no. 7:999-1014. PNNL-SA-161620. doi:10.1016/j.ccell.2021.06.003

2020

• Gao Y., Y. Wang, Y. Chen, H. Wang, D. Young, T. Shi, and Y. Song, et al. 2020. "Proteomic Tissue-based Classifier for Early Prediction of Prostate Cancer Progression." Cancers 12, no. 5:1268. PNNL-SA-149705. doi:10.3390/cancers12051268
• Ilhan Z.E., J.K. DiBaise, S.E. Dautel, N.G. Isern, Y. Kim, D.W. Hoyt, and A.A. Schepmoes, et al. 2020. "Temporospatial shifts in the human gut microbiome and metabolome after gastric bypass surgery." NPJ Biofilms and Microbiomes 6, no. 1:Article No. 12. PNNL-SA-133750. doi:10.1038/s41522-020-0122-5
• Kaiser B., J.M. Jacobs, A.A. Schepmoes, H.M. Brewer, B.M. Webb-Robertson, S. Valtier, and V.S. Bebarta, et al. 2020. "Assessment of the Utility of the Oral Fluid and Plasma Proteome for Hydrocodone Usage." Journal of Medical Toxicology 16, no. 1:49-60. PNNL-SA-121218. doi:10.1007/s13181-019-00731-0
• Lee J., T. Shi, V.A. Petyuk, A.A. Schepmoes, T.L. Fillmore, Y. Wang, and W.A. Cardoni, et al. 2020. "Detection of head and neck cancer based on longitudinal changes in serum protein abundance." Cancer Epidemiology, Biomarkers and Prevention 29, no. 8:1665-1672. PNNL-ACT-SA-10471. doi:10.1158/1055-9965.EPI-20-0192
• McDermott J.E., O.A. Arshad, V.A. Petyuk, Y. Fu, M.A. Gritsenko, T.R. Clauss, and R.J. Moore, et al. 2020. "Proteogenomic characterization of ovarian HGSC implicates mitotic kinases, replication stress in observed chromosomal instability." Cell Reports Medicine 1, no. 1:Article No. 100004. PNNL-SA-145681. doi:10.1016/j.xcrm.2020.100004

2019

• Stevens S., T. Liu, F.R. Bahjat, V.A. Petyuk, A.A. Schepmoes, R.L. Sontag, and M.A. Gritsenko, et al. 2019. "Preconditioning in the Rhesus Macaque Induces a Proteomic Signature Following Cerebral Ischemia that Is Associated with Neuroprotection." Translational Stroke Research 10, no. 4:440-448. PNWD-SA-10567. doi:10.1007/s12975-018-0670-7
• Stevens S.L., T. Liu, F.R. Bahjat, V.A. Petyuk, A.A. Schepmoes, R.L. Sontag, and M.A. Gritsenko, et al. 2019. "Preconditioning in the Rhesus Macaque Induces a Proteomic Signature Following Cerebral Ischemia That Is Associated With Neuroprotection." Translational Stroke Research 10, no. 4:440-448. PNNL-SA-153569. doi:10.1007/s12975-018-0670-7

2018

• Stanfill B.A., E.S. Nakayasu, L.M. Bramer, A.M. Thompson, C.K. Ansong, T. Clauss, and M.A. Gritsenko, et al. 2018. "Quality Control Analysis in Real-time (QC-ART): A Tool for Real-time Quality Control Assessment of Mass Spectrometry-based Proteomics Data." Molecular & Cellular Proteomics 17, no. 9:1824-1836. PNNL-SA-129934. doi:10.1074/mcp.RA118.000648

2017

• Nie S., T. Shi, T.L. Fillmore, A.A. Schepmoes, H.M. Brewer, Y. Gao, and E. Song, et al. 2017. "Deep-dive Targeted Quantification for Ultrasensitive Analysis of Proteins in Nondepleted Human Blood Plasma/Serum and Tissues." Analytical Chemistry 89, no. 17:9139-9146. PNNL-SA-126297. doi:10.1021/acs.analchem.7b01878
• Song E., Y. Gao, C. Wu, T. Shi, S. Nie, T.L. Fillmore, and A.A. Schepmoes, et al. 2017. "Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer." Scientific Data. PNNL-SA-122408. doi:10.1038/sdata.2017.91
• Thangella P.A., A. Ladak, A.A. Schepmoes, H.J. Olivos, K. Zhao, S.J. Callister, and L.E. Bartley. 2017. "Proteomics Coupled with Metabolite and Cell Wall Profiling Reveal Metabolic Processes of a Developing Rice Stem Internode." Frontiers in Plant Science 8. PNNL-SA-126832. doi:10.3389/fpls.2017.01134
• Wang H., C.E. Barbieri, J. He, Y. Gao, T. Shi, C. Wu, and A.A. Schepmoes, et al. 2017. "Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics." Journal of Translational Medicine 15. PNNL-SA-125993. doi:10.1186/s12967-017-1276-7

2016

• Hatakeyama H., S.Y. Wu, Y.A. Lyons, S. Pradeep, W. Wang, Q. Huang, and K.A. Court, et al. 2016. "Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers." Cell Reports 17, no. 6:1621-1631. PNNL-SA-120868. doi:10.1016/j.celrep.2016.10.020
• Nakayasu E.S., C.D. Nicora, A.C. Sims, K.E. Burnum-Johnson, Y. Kim, J.E. Kyle, and M.M. Matzke, et al. 2016. "MPLEx: a Robust and Universal Protocol for Single-Sample Integrative Proteomic, Metabolomic, and Lipidomic Analyses." mSystems 1, no. 3:e00043-16. PNNL-SA-114737. doi:10.1128/mSystems.00043-16
• Nielson C., K. Jones, R.F. Chun, J.M. Jacobs, Y. Wang, M. Hewison, and J.S. Adams, et al. 2016. "Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations." Journal of Clinical Endocrinology and Metabolism 101, no. 5:2226-2234. PNNL-SA-120076. doi:10.1210/jc.2016-1104
• Tisoncik-Go J., D.J. Gasper, J.E. Kyle, A.J. Eisfeld, C. Selinger, M. Hatta, and J. Morrison, et al. 2016. "Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism." Cell Host & Microbe 19, no. 2:254-66. PNWD-SA-10483. doi:10.1016/j.chom.2016.01.002

2015

• He J., A.A. Schepmoes, T. Shi, C. Wu, T.L. Fillmore, Y. Gao, and R.D. Smith, et al. 2015. "Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods." Journal of Translational Medicine 13. PNNL-SA-107827. doi:10.1186/s12967-015-0418-z
• Townsend P., Q. Zhang, J. Shapiro, B.M. Webb-Robertson, L.M. Bramer, A.A. Schepmoes, and K.K. Weitz, et al. 2015. "Serum Proteome Profiles in Stricturing Crohn’s Disease: A pilot study." Inflammatory Bowel Diseases 21, no. 8:1935-41. PNNL-SA-108499. doi:10.1097/MIB.0000000000000445
• Xu Z., C. Wu, F. Xie, G.W. Slysz, N. Tolic, M.E. Monroe, and V.A. Petyuk, et al. 2015. "Comprehensive Quantitative Analysis of Ovarian and Breast Cancer Tumor Peptidomes." Journal of Proteome Research 14, no. 1:422-433. PNNL-SA-103951. doi:10.1021/pr500840w

2014

• Aevermann B., B.E. Pickett, S. Kumar, E.B. Klem, S. Agnihothram, P.S. Askovich, and A. Bankhead, et al. 2014. "A Comprehensive Collection of Systems Biology Data Characterizing the Host Response to Viral Infection." Scientific Data 1. PNNL-SA-101269. doi:10.1038/sdata.2014.33
• He J., X. Sun, T. Shi, A.A. Schepmoes, T.L. Fillmore, V.A. Petyuk, and F. Xie, et al. 2014. "Antibody-independent Targeted Quantification of TMPRSS2-ERG Fusion Protein Products in Prostate Cancer." Molecular Oncology 8, no. 7:1169-1180. PNNL-SA-97917. doi:10.1016/j.molonc.2014.02.004
• Hyung S., P.D. Piehowski, R.J. Moore, D.J. Orton, A.A. Schepmoes, T.R. Clauss, and R.K. Chu, et al. 2014. "Microscale Depletion of High Abundance Proteins in Human Biofluids using IgY14 Immunoaffinity Resin: Analysis of Human Plasma and Cerebrospinal Fluid." Analytical and Bioanalytical Chemistry 406, no. 28:7117-7125. PNNL-SA-92758. doi:10.1007/s00216-014-8058-3
• Menachery V., A.J. Eisfeld, A. Schafer, L. Josset, A.C. Sims, S. Proll, and S. Fan, et al. 2014. "Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches to Control Interferon-Stimulated Gene Responses." mBio 5, no. 3:Article No. e01174-14. PNWD-SA-9990. doi:10.1128/mBio.01174-14
• Zhang Q., M.M. Matzke, A.A. Schepmoes, R.J. Moore, B.M. Webb-Robertson, Z. Hu, and M.E. Monroe, et al. 2014. "High and Low Doses of Ionizing Radiation Induce Different Secretome Profiles in a Human Skin Model." PLoS One 9, no. 3:Article No. e92332. PNNL-SA-98075. doi:10.1371/journal.pone.0092332

2013

• Mitchell H.D., A.J. Eisfeld, A. Sims, J.E. McDermott, M.M. Matzke, B.M. Webb-Robertson, and S.C. Tilton, et al. 2013. "A Network Integration Approach to Predict Conserved Regulators Related to Pathogenicity of Influenza and SARS-CoV Respiratory Viruses." PLoS One 8, no. 7:e69374. PNNL-SA-92748. doi:10.1371/journal.pone.0069374
• Schutzer S.E., T.E. Angel, T. Liu, A.A. Schepmoes, F. Xie, J.P. Bergquist, and L. Vecsei, et al. 2013. "Gray Matter Is Targeted in First-Attack Multiple Sclerosis." PLoS One 8, no. 9:E6617. PNNL-SA-98547. doi:10.1371/journal.pone.0066117
• Shi T., T.L. Fillmore, Y. Gao, R. Zhao, J. He, A.A. Schepmoes, and C.D. Nicora, et al. 2013. "Long-Gradient Separations Coupled with Selected Reaction Monitoring for Highly Sensitive, Large Scale Targeted Protein Quantification in a Single Analysis." Analytical Chemistry 85, no. 19:9196-9203. PNNL-SA-96700. doi:10.1021/ac402105s
• Shi T., X. Sun, Y. Gao, T.L. Fillmore, A.A. Schepmoes, R. Zhao, and J. He, et al. 2013. "Targeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletion." Journal of Proteome Research 12, no. 7:3353-3361. PNNL-SA-92544. doi:10.1021/pr400178v
• Zhang Q., T.L. Fillmore, A.A. Schepmoes, T.R. Clauss, M.A. Gritsenko, P.W. Mueller, and M. Rewers, et al. 2013. "Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes." The Journal of Experimental Medicine 210, no. 1:191-203. PNNL-SA-89853. doi:10.1084/jem.20111843

2012

• Cao L., D.A. Bryant, A.A. Schepmoes, K. Vogl, R.D. Smith, M.S. Lipton, and S.J. Callister. 2012. "Comparison of Chloroflexus aurantiacus strain J-10-fl proteomes of cells grown chemoheterotrophically and photoheterotrophically." Photosynthesis Research 110, no. 3:153-168. PNNL-SA-81058. doi:10.1007/s11120-011-9711-8
• Liu T., M. Hossain, A.A. Schepmoes, T.L. Fillmore, L.J. Sokoll, S.R. Kronewitter, and G. Izmirlian, et al. 2012. "Analysis of Serum Total and Free PSA Using Immunoaffinity Depletion Coupled to SRM: Correlation with Clinical Immunoassay Tests." Journal of Proteomics 75, no. 15:4747-4757. PNNL-SA-83777. doi:10.1016/j.jprot.2012.01.035
• Shi T., T.L. Fillmore, X. Sun, R. Zhao, A.A. Schepmoes, M. Hossain, and F. Xie, et al. 2012. "Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum." Proceedings of the National Academy of Sciences of the United States of America 109, no. 38:15395-15400. PNNL-SA-83776. doi:10.1073/pnas.1204366109

2011

• Niemann G., R.N. Brown, J.K. Gustin, A. Stufkens, A.S. Shaikh-Kidwai, J. Li, and J.E. McDermott, et al. 2011. "Discovery of Novel Secreted Virulence Factors from Salmonella enterica Serovar Typhimurium by Proteomic Analysis of Culture Supernatants." Infection and Immunity 79, no. 1:33-43. PNNL-SA-71385. doi:10.1128/IAI.00771-10
• Schoenherr R.M., K.S. Kelly-Spratt, C. Lin, J.R. Whiteaker, T. Liu, T. Holzman, and I. Coleman, et al. 2011. "Proteome and Transcriptome Profiles of a Her2/Neu-driven Mouse Model of Breast Cancer." Proteomics - Clinical Applications 5, no. 3-4:179-188. PNNL-SA-72407. doi:10.1002/prca.201000037
• Schutzer S.E., T.E. Angel, T. Liu, A.A. Schepmoes, T.R. Clauss, J.N. Adkins, and D.G. Camp, et al. 2011. "Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome." PLoS One 6, no. 2:Article No. e17287. PNWD-SA-9128. doi:10.1371/journal.pone.0017287
• Shen Y., N. Tolic, F. Xie, R. Zhao, S.O. Purvine, A.A. Schepmoes, and R.J. Moore, et al. 2011. "Effectiveness of CID, HCD, and ETD with FT MS/MS for degradomic-peptidomic analysis: comparison of peptide identification methods." Journal of Proteome Research 10, no. 9:3929-3943. PNNL-SA-75441. doi:10.1021/pr200052c
• Zhang Q., M.E. Monroe, A.A. Schepmoes, T.R. Clauss, M.A. Gritsenko, D. Meng, and V.A. Petyuk, et al. 2011. "Comprehensive Identification of Glycated Peptides and Their Glycation Motifs in Plasma and Erythrocytes of Control and Diabetic Subjects." Journal of Proteome Research 10, no. 7:3076-3088. PNNL-SA-77801.

2010

• Baker E.S., E.A. Livesay, D.J. Orton, R.J. Moore, W.F. Danielson, D.C. Prior, and Y.M. Ibrahim, et al. 2010. "An LC-IMS-MS Platform Providing Increased Dynamic Range for High-Throughput Proteomic Studies." Journal of Proteome Research 9, no. 2:997-1006. PNNL-SA-67461. doi:10.1021/pr900888b
• Brown R.N., M.F. Romine, A.A. Schepmoes, R.D. Smith, and M.S. Lipton. 2010. "Mapping the Subcellular Proteome of Shewanella oneidensis MR-1 using Sarkosyl-based fractionation and LC-MS/MS protein identification." Journal of Proteome Research 9, no. 9:4454-4463. PNNL-SA-70091. doi:10.1021/pr100215h
• Qian W., B.O. Petritis, A. Kaushal, C.C. Finnerty, M.G. Jescheke, M.E. Monroe, and R.J. Moore, et al. 2010. "Plasma Proteome Response to Severe Burn Injury Revealed by 18O-Labeled “Universal” Reference-based Quantitative Proteomics." Journal of Proteome Research 9, no. 9:4779-4789. PNWD-SA-9014.
• Schutzer S.E., T. Liu, B. Natelson, T.E. Angel, A.A. Schepmoes, S.O. Purvine, and K.K. Hixson, et al. 2010. "Establishing the Proteome of Normal Human Cerebrospinal Fluid." PLoS One 5, no. 6:e10980-. PNWD-SA-8931. doi:10.1371/journal.pone.0010980
• Zhang X., J. Zhou, M.H. Chin, A.A. Schepmoes, V.A. Petyuk, K.K. Weitz, and B.O. Petritis, et al. 2010. "Region-Specific Protein Abundance Changes in the Brain of MPTP-induced Parkinson’s Disease Mouse Model." Journal of Proteome Research 9, no. 3:1496-1509. PNNL-SA-67444. doi:10.1021/pr901024z
• Zhang X., M.E. Monroe, B. Chen, M.H. Chin, T.H. Heibeck, A.A. Schepmoes, and F. Yang, et al. 2010. "Endogenous 3, 4- Dihydroxyphenylalanine and Dopaquinone Modifications on Protein Tyrosine: links to mitochondrially derived oxidative stress via hydroxyl radical." Molecular & Cellular Proteomics. MCP 9, no. 6:1199-1208. PNNL-SA-65899.
• Zhou J., A.A. Schepmoes, X. Zhang, R.J. Moore, M.E. Monroe, J. Lee, and D.G. Camp, et al. 2010. "Improved LC-MS/MS Spectral Counting Statistics by Recovering Low Scoring Spectra Matched to Confidently Identified Peptide Sequences." Journal of Proteome Research 9, no. 11:5698-5704. PNNL-SA-74147. doi:10.1021/pr100508p

2009

• Heibeck T.H., S. Ding, L.K. Opresko, R. Zhao, A.A. Schepmoes, F. Yang, and A.V. Tolmachev, et al. 2009. "An Extensive Survey of Tyrosine Phosphorylation Revealing New Sites in Human Mammary Epithelial Cells." Journal of Proteome Research 8, no. 8:3852-3861. PNNL-SA-63993.
• Schepmoes A.A., Q. Zhang, B.O. Petritis, W. Qian, and R.D. Smith. 2009. "N-Terminal Enrichment: Developing a Protocol to Detect Specific Proteolytic Fragments." Journal of Biomolecular Techniques:JBT 20, no. 5:263-265. PNNL-SA-75602.

2008

• Zhang Q., A.A. Schepmoes, J.W. Brock, S. Wu, R.J. Moore, S.O. Purvine, and J. Baynes, et al. 2008. "Improved Methods for the Enrichment and Analysis of Glycated Peptides." Analytical Chemistry 80, no. 24:9822-9829. PNNL-SA-61746. doi:10.1021/ac801704j
• Zhang Q., N. Tang, A.A. Schepmoes, L.S. Phillips, R.D. Smith, and T.O. Metz. 2008. "Proteomic Profiling of Nonenzymatically Glycated Proteins in Human Plasma and Erythrocyte Membrane." Journal of Proteome Research 7, no. 5:2025-2032. PNNL-SA-57905. doi:10.1021/pr700763r
• Zhang Q., V.A. Petyuk, A.A. Schepmoes, D.J. Orton, M.E. Monroe, F. Yang, and R.D. Smith, et al. 2008. "Analysis of Non-Enzymatically Glycated Peptides: Neutral-Loss Triggered MS3 Versus Multi-Stage Activation Tandem Mass Spectrometry." Rapid Communications in Mass Spectrometry 22, no. 19:3027-3034. PNNL-SA-61116. Analysis of Non-Enzymatically Glycated Peptides: Neutral-Loss Triggered MS3 Versus Multi-Stage Activation Tandem Mass Spectrometry">doi:10.1002/rcm.3703Analysis of Non-Enzymatically Glycated Peptides: Neutral-Loss Triggered MS3 Versus Multi-Stage Activation Tandem Mass Spectrometry

2006

• Shi L., J.N. Adkins, J.R. Coleman, A.A. Schepmoes, A. Dohnalkova, H.M. Mottaz, and A.D. Norbeck, et al. 2006. "Proteomic Analysis of Salmonella enterica Serovar Typhimurium Isolated from RAW 264.7 Macrophages: identification of a novel protein that contributes to the replication of serovar Typhimurium inside macrophages." Journal of Biological Chemistry 281. PNNL-SA-51416. doi:10.1074/jbc.M604640200